Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/18/16 → 06/13/19 |
Funding
- National Cancer Institute: $1.00
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
- Keresztes, Roger (PI)
- Kudelka, Andrzej (CoPI)
Project: Research